Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ivette Buendía-Roldán, Rosario Fernandez, Mayra Mejía, Fortunato Juarez, Gustavo Ramirez-Martinez, Eduardo Montes, Ana Karem S. Pruneda, Karen Martinez-Espinosa, Aime Alarcon-Dionet, Iliana Herrera, Carina Becerril, Leslie Chavez-Galan, Mario Preciado, Annie Pardo, Moisés Selman. Risk factors associated with the development of interstitial lung abnormalities. Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020

Member's Comments

No comment yet.

Related content which might interest you: Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018 Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018 Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Interstitial lung abnormalities in smokers are associated with increased mortality Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Risk factors for lung involvements in patients with Sjögren's syndrome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Risk factors associated with death in pulmonary tuberculosis Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Prevalence of abnormal lung function and age-dependent risk factors in the general population Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021